News

Santé log23h
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Public exchange offer for all shares of CureVac where each share of CureVac will be exchanged for approx. $5.46 in BioNTech American Depositary Shares (“ADSs”), representing a premium of 55% to ...
Cheddar News1h
Big Business This Week: What’s the smart bet on the future of energy?
AI data centers need energy, and that’s what’s made the stock price of aptly-named NRG $NRG rise 88% in the past year ...
Cantech Letter22h
As Public Cancer Funding Wavers, Oncology’s Brightest Breakthroughs Are Coming From Industry
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /CNW/ — Equity Insider News Commentary – The 2025 ASCO Annual Meeting has ...
Investing.com Australia19h
Lawmakers push to ban direct-to-consumer drug advertising, WSJ reports
The bill echoes long-standing criticisms that such advertising fuels over-prescription and inflates healthcare costs. It also ...
Equity Insider: As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...